-
1دورية أكاديمية
المؤلفون: Huang, Fang, Cui, Jian, Wan, Jingxuan, Yuan, Xue, Zhu, Yuanzhe, Wu, Xiangxiang, Zuo, WeiAff1, IDs00432023054164_cor7, Zhao, TiantianAff1, IDs00432023054164_cor8
المصدر: Journal of Cancer Research and Clinical Oncology. 149(18):16729-16739
-
2دورية أكاديمية
المؤلفون: Nitin Roper, Anna-Leigh Brown, Jun S. Wei, Svetlana Pack, Christopher Trindade, Chul Kim, Olivia Restifo, Shaojian Gao, Sivasish Sindiri, Farid Mehrabadi, Rajaa El Meskini, Zoe Weaver Ohler, Tapan K. Maity, Abhilash Venugopalan, Constance M. Cultraro, Elizabeth Akoth, Emerson Padiernos, Haobin Chen, Aparna Kesarwala, DeeDee K. Smart, Naris Nilubol, Arun Rajan, Zofia Piotrowska, Liqiang Xi, Mark Raffeld, Anna R. Panchenko, Cenk Sahinalp, Stephen Hewitt, Chuong D. Hoang, Javed Khan, Udayan Guha
المصدر: Cell Reports Medicine, Vol 1, Iss 1, Pp 100007- (2020)
مصطلحات موضوعية: EGFR mutant lung cancer, non-small cell lung cancer, osimertinib, MET amplification, copy number ampplifications, neuroendocrine differentiation, Medicine (General), R5-920
وصف الملف: electronic resource
-
3دورية أكاديمية
المصدر: Frontiers in Genetics, Vol 11 (2020)
مصطلحات موضوعية: EGFR mutant lung cancer, EGFR tyrosine kinase inhibitors, acquired resistance, lineage plasticity, epithelial-mesenchymal transition, neuroendocrine transformation, Genetics, QH426-470
وصف الملف: electronic resource
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
المؤلفون: Bosc, Cecile, Ferretti, Gilbert R., Cadranel, Jacques, Audigier-Valette, Clarisse, Besse, Benjamin, Barlesi, Fabrice, Decroisette, Chantal, Lantuejoul, Sylvie, Arbib, François, Moro-Sibilot, Denis
المصدر: Targeted Oncology. June 2015 10(2):247-253
-
7
المؤلفون: Daniel G. Tenen, Fhu Chee Wai, Elena Levantini, Thomas C. Putti, Wanjin Hong, Eva Csizmadia, Jeff Settleman, John G. Clohessy, Margaret P. Quinlan, Chen Xie, Azhar Ali, Tan Min Chin, Ellen P S Man, Boon Cher Goh, Seow-Ching Wan, Gandhi T K Boopathy, Yan Shan Ong
المصدر: Theranostics
Theranostics 10 (2020): 2727–2743. doi:10.7150/thno.38729
info:cnr-pdr/source/autori:Chin T.-M.; Boopathy G.T.K.; Man E.P.S.; Clohessy J.G.; Csizmadia E.; Quinlan M.P.; Putti T.; Wan S.-C.; Xie C.; Ali A.; Wai F.C.; Ong Y.S.; Goh B.-C.; Settleman J.; Hong W.; Levantini E.; Tenen D.G./titolo:Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors/doi:10.7150%2Fthno.38729/rivista:Theranostics/anno:2020/pagina_da:2727/pagina_a:2743/intervallo_pagine:2727–2743/volume:10مصطلحات موضوعية: 0301 basic medicine, Genetically modified mouse, Lung Neoplasms, Endosome, Medicine (miscellaneous), Antineoplastic Agents, Mice, Transgenic, EGFR mutants, Magnetic resonance Imaging, Molecular pathogenesis of lung cancer, NSCLC, Immunofluorescence, Microtubules, chloroquine, Drug treatment, Mice, 03 medical and health sciences, 0302 clinical medicine, Microtubule, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Lysosome, Chlorocebus aethiops, tyrosine kinase inhibitors, medicine, Animals, Humans, Protein Kinase Inhibitors, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Preclinical murine model of lung cancer, medicine.diagnostic_test, LAMP1, Chemistry, Kinase, 3. Good health, ErbB Receptors, 030104 developmental biology, medicine.anatomical_structure, Drug Resistance, Neoplasm, Tumor progression, EGFR mutant lung cancer therapy, 030220 oncology & carcinogenesis, COS Cells, Cancer research, Lysosomes, microtubule dysfunction, Research Paper
-
8
المؤلفون: Yusuke Shinozaki, Kei Morikawa, Takeo Inoue, Masamichi Mineshita, Hiroki Nishine, Masahiro Iinuma
المصدر: Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 13 (2021)مصطلحات موضوعية: Metastatic lesions, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Mutually exclusive events, EGFR-mutant lung cancer, BRAF-mutant lung cancer, Oncology, double driver mutation, Mutation (genetic algorithm), medicine, Cancer research, Adenocarcinoma, case report, business, Lung cancer, Gene, RC254-282
-
9
المؤلفون: Tuo Zhang, Haitang Yang, Ralph A. Schmid, Duilio Divisi, Beibei Sun, Chenxi Zhong, Paul Hofman, Ke Xu, Biagio Ricciuti, Feng Yao, Daniel Breadner, Zhexin Wang, Ren-Wang Peng, Tatsuya Nagano, Antoine Legras
المصدر: Zhang, Tuo; Sun, Beibei; Zhong, Chenxi; Xu, Ke; Wang, Zhexin; Hofman, Paul; Nagano, Tatsuya; Legras, Antoine; Breadner, Daniel; Ricciuti, Biagio; Divisi, Duilio; Schmid, Ralph A.; Peng, Ren-Wang; Yang, Haitang; Yao, Feng (2021). Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma. Translational lung cancer research, 10(4), pp. 1857-1872. AME Publishing 10.21037/tlcr-21-303 <http://dx.doi.org/10.21037/tlcr-21-303>
Transl Lung Cancer Resمصطلحات موضوعية: 0301 basic medicine, medicine.drug_class, Cell, Resistance, 610 Medicine & health, medicine.disease_cause, EGFR-mutant lung cancer, Ferroptosis, Histone deacetylase, 03 medical and health sciences, 0302 clinical medicine, Downregulation and upregulation, Epidermal growth factor, medicine, Osimertinib, Vorinostat, business.industry, Histone deacetylase inhibitor, respiratory tract diseases, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cancer research, Original Article, business, Carcinogenesis, medicine.drug
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f8578ca48b257de7435816265a70cb
http://hdl.handle.net/11697/177405 -
10
المصدر: Frontiers in Genetics
Frontiers in Genetics, Vol 11 (2020)مصطلحات موضوعية: 0301 basic medicine, lcsh:QH426-470, medicine.medical_treatment, epithelial-mesenchymal transition, neuroendocrine transformation, Context (language use), lineage plasticity, Review, Neuroendocrine differentiation, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Adenocarcinoma of the lung, medicine, Genetics, EGFR mutant lung cancer, EGFR tyrosine kinase inhibitors, Epithelial–mesenchymal transition, Epidermal growth factor receptor, Epigenetics, Lung cancer, Rb1, Genetics (clinical), biology, business.industry, acquired resistance, medicine.disease, respiratory tract diseases, lcsh:Genetics, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Molecular Medicine, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3932c9f886bf63851a627053491bf9ce
http://europepmc.org/articles/PMC7121227